Search PubMed⌕ Search

Biomedical subjects

J Nagington

Publications and source records attributed to J Nagington.

54 records · Page 3Linked to original sources
PubMed1976

Chemotherapeutic compounds and Acanthamoebae from eye infections.

The amoebicidal and amoebistatic action in vitro of 24 compounds was tested on two strains of Acanthamoeba, A. polyphaga and A. castellanii, isolated from eye infections in this country. For comparison, the Ryan strain of A. castellanii and Naegleria gruberi L-1 were also examined. Nine compounds showed sufficient activity to merit further consideration, ie, acriflavine, proflavine, hydroxystilbamidine isethionate, paromomycin, miconazole, amphoterin, neomycin, polymyxin, and the last two combined in Neosporin.

Acriflavine↗
PubMed1975

Isolation of amoebae from eye infections in England.

The laboratory investigations are presented on the first two recorded cases in England of infection of the eye by free-living amoebae. The distribution and pathogenicity of these amoebae are briefly discussed and some therapeutic possibilities derived from subsequent in vitro studies.

Adult↗
PubMed1971

Cytomegalovirus antibody production in renal transplant patients.

Sera were examined from 50 patients on the renal transplant unit, Cambridge, for antibody against cytomegalovirus by complement fixation and by immunofluorescence for IgG and IgM antibodies.The incidence of antibody on admission was 84% with a possible further 8% so that nearly all had been infected at some time by CMV.43 (86%) patients showed evidence of active infection after admission, 39 by serology and four only from the examination of post-mortem material.Twenty-one patients produced IgM antibody and production was prolonged for years in patients that survived. Antibody production was related both to transplantation and admission to hospital.The evidence indicated that primary CMV infections were rare, that IgM antibody production was the result of active infection and that this could be attributed to reactivation without the need to invoke re-infection as the source although this type of patient is both susceptible and exposed to re-infection.

Antibodies↗